Immense Scope for New Entrants and Innovative Applications Makes Biochips an Attractive Investment, Says TMR
The global biochips market is projected to expand at a steady 16.9% CAGR over the course of the forecast period, with the value of this market rising from US$5.7 bn in 2104 to US$22.2 bn by 2023. DNA chips form the largest segment by type in terms of revenue, with a 39.7% share in 2014. Microfluidic devices, on the other hand, are anticipated to expand at the highest CAGR of 17.4% from 2015 to 2023. Among applications, drug discovery and...
View full press release